The effectiveness of cardiac telerehabilitation in comparison to centre-based cardiac rehabilitation programmes: A literature review.

cardiology ehealth literatire review telehealth telemedicine telerehabilitation

Journal

Journal of telemedicine and telecare
ISSN: 1758-1109
Titre abrégé: J Telemed Telecare
Pays: England
ID NLM: 9506702

Informations de publication

Date de publication:
May 2024
Historique:
medline: 19 4 2024
pubmed: 5 4 2022
entrez: 4 4 2022
Statut: ppublish

Résumé

Cardiac rehabilitation (CR) is an effective, yet under-utilised, form of secondary prevention in cardiac patients. Telemedicine is one method of overcoming barriers to accessing CR. Previous systematic reviews highlight variation in the effectiveness of telerehabilitation programmes and current literature lacks identification of which telemedicine interventions are most effective, despite differences in the results of primary studies. The objectives of this literature review were to: evaluate the effectiveness of cardiac telerehabilitation compared to centre-based programmes for managing cardiac risk factors, satisfaction and adherence in cardiac patients; identify the technologies used to deliver CR; identify the key components of effective interventions. A literature search was conducted using MEDLINE, EMBASE and Scopus. Randomised controlled trials (RCTs) involving an intervention group that received telerehabilitation and a control group that attended a CR centre were included. Twelve RCTs met the inclusion criteria. There is evidence to suggest that telerehabilitation programmes have similar effectiveness to centre-based CR. Phones were the most commonly used technology. Most studies used a combination of technologies including personal computers and self-monitoring equipment. Phase III telerehabilitation programmes using self-monitoring, motivational feedback and education were more effective than centre-based CR for increasing physical activity and functional capacity. Cardiac telerehabilitation is delivered by a range of technologies and has a similar effectiveness to centre-based programmes. While evidence suggests that additional health benefits are seen in patients who receive a telemedicine intervention in Phase III of CR, further evidence would be required to confidently draw this conclusion.

Identifiants

pubmed: 35369770
doi: 10.1177/1357633X221085865
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

631-646

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Eur J Prev Cardiol. 2020 Nov;27(16):1782-1792
pubmed: 32106713
BJOG. 2018 Dec;125(13):1716
pubmed: 29916205
Eur J Prev Cardiol. 2020 Jun;27(9):912-928
pubmed: 31581808
Heart. 2016 Dec 15;102(24):1945-1952
pubmed: 27550425
Eur J Prev Cardiol. 2015 Jan;22(1):35-74
pubmed: 23943649
Eur J Cardiovasc Prev Rehabil. 2010 Feb;17(1):1-17
pubmed: 19952757
Eur Heart J. 2015 May 14;36(19):1163-70
pubmed: 25586123
Eur J Prev Cardiol. 2015 Aug;22(8):959-71
pubmed: 25488550
Prog Cardiovasc Dis. 2014 Mar-Apr;56(5):522-9
pubmed: 24607017
Heart. 2019 Jan;105(2):122-129
pubmed: 30150328
Eur J Prev Cardiol. 2020 Mar;27(4):367-377
pubmed: 31787026
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
Am Heart J. 2009 Nov;158(5):852-9
pubmed: 19853708
Am Heart J. 2017 Jun;188:65-72
pubmed: 28577682
Circulation. 2011 Nov 29;124(22):2458-73
pubmed: 22052934
BMC Cardiovasc Disord. 2017 Feb 20;17(1):66
pubmed: 28219338
J Telemed Telecare. 2021 Sep;27(8):473-483
pubmed: 31760855
Eur J Prev Cardiol. 2015 Dec;22(12):1513-22
pubmed: 25452626
J Telemed Telecare. 2011;17(5):217-21
pubmed: 21508077
Digit Health. 2018 Sep 03;4:2055207618797554
pubmed: 30202544
Arch Phys Med Rehabil. 2015 Sep;96(9):1733-8
pubmed: 26073758
Mayo Clin Proc. 2017 Feb;92(2):234-242
pubmed: 27855953
Vasc Health Risk Manag. 2013;9:485-91
pubmed: 24039433
Eur J Prev Cardiol. 2017 Aug;24(12):1260-1273
pubmed: 28534417
Mayo Clin Proc. 2016 Feb;91(2):140-8
pubmed: 26682921
Heart Vessels. 2017 Apr;32(4):408-418
pubmed: 27730298
Clin Cardiol. 2019 Mar;42(3):391-399
pubmed: 30697776
Eur J Prev Cardiol. 2017 Nov;24(16):1708-1717
pubmed: 28925749
J Telemed Telecare. 2014 Oct;20(7):419-22
pubmed: 25400004
J Physiother. 2017 Apr;63(2):101-107
pubmed: 28336297

Auteurs

Olivia Owen (O)

School of Medicine, University of St Andrews, St Andrews, Scotland.

Veronica O'Carroll (V)

School of Medicine, University of St Andrews, St Andrews, Scotland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH